These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Iminosugar Glucosidase Inhibitors Reduce Hepatic Inflammation in Hepatitis A Virus-Infected Misumi I; Li Z; Sun L; Das A; Shiota T; Cullen J; Zhang Q; Whitmire JK; Lemon SM J Virol; 2021 May; 95(11):e0005821. PubMed ID: 33692213 [TBL] [Abstract][Full Text] [Related]
24. Study of the mechanism of antiviral action of iminosugar derivatives against bovine viral diarrhea virus. Durantel D; Branza-Nichita N; Carrouée-Durantel S; Butters TD; Dwek RA; Zitzmann N J Virol; 2001 Oct; 75(19):8987-98. PubMed ID: 11533162 [TBL] [Abstract][Full Text] [Related]
25. Strain-specific antiviral activity of iminosugars against human influenza A viruses. Hussain S; Miller JL; Harvey DJ; Gu Y; Rosenthal PB; Zitzmann N; McCauley JW J Antimicrob Chemother; 2015 Jan; 70(1):136-52. PubMed ID: 25223974 [TBL] [Abstract][Full Text] [Related]
26. Mechanisms of Antiviral Activity of Iminosugars Against Dengue Virus. Miller JL; Tyrrell BE; Zitzmann N Adv Exp Med Biol; 2018; 1062():277-301. PubMed ID: 29845540 [TBL] [Abstract][Full Text] [Related]
27. Enhancing the antiviral potency of ER α-glucosidase inhibitor IHVR-19029 against hemorrhagic fever viruses in vitro and in vivo. Ma J; Zhang X; Soloveva V; Warren T; Guo F; Wu S; Lu H; Guo J; Su Q; Shen H; Solon E; Comunale MA; Mehta A; Guo JT; Bavari S; Du Y; Block TM; Chang J Antiviral Res; 2018 Feb; 150():112-122. PubMed ID: 29253498 [TBL] [Abstract][Full Text] [Related]
28. Iminosugars: Promising therapeutics for influenza infection. Tyrrell BE; Sayce AC; Warfield KL; Miller JL; Zitzmann N Crit Rev Microbiol; 2017 Sep; 43(5):521-545. PubMed ID: 27931136 [TBL] [Abstract][Full Text] [Related]
29. In Planta Preliminary Screening of ER Glycoprotein Folding Quality Control (ERQC) Modulators. Marti L; Lia A; Reca IB; Roversi P; Santino A; Zitzmann N Int J Mol Sci; 2018 Jul; 19(7):. PubMed ID: 30041423 [TBL] [Abstract][Full Text] [Related]
30. Stable analogues of nojirimycin--synthesis and biological evaluation of nojiristegine and manno-nojiristegine. Viuff AH; Besenbacher LM; Kamori A; Jensen MT; Kilian M; Kato A; Jensen HH Org Biomol Chem; 2015 Oct; 13(37):9637-58. PubMed ID: 26264193 [TBL] [Abstract][Full Text] [Related]
31. An overview of therapeutic potential of N-alkylated 1-deoxynojirimycin congeners. Iftikhar M; Lu Y; Zhou M Carbohydr Res; 2021 Jun; 504():108317. PubMed ID: 33932806 [TBL] [Abstract][Full Text] [Related]
33. Identification of Endoplasmic Reticulum α-Glucosidase I from a Thermophilic Fungus as a Platform for Structure-Guided Antiviral Drug Design. Karade SS; Kolesnikov A; Treston AM; Mariuzza RA Biochemistry; 2022 May; 61(10):822-832. PubMed ID: 35476408 [TBL] [Abstract][Full Text] [Related]
34. Reduction of the infectivity of hepatitis C virus pseudoparticles by incorporation of misfolded glycoproteins induced by glucosidase inhibitors. Chapel C; Garcia C; Bartosch B; Roingeard P; Zitzmann N; Cosset FL; Dubuisson J; Dwek RA; Trépo C; Zoulim F; Durantel D J Gen Virol; 2007 Apr; 88(Pt 4):1133-1143. PubMed ID: 17374756 [TBL] [Abstract][Full Text] [Related]
35. Polyhydroxylated Quinolizidine Iminosugars as Nanomolar Selective Inhibitors of α-Glucosidases. Vieira Da Cruz A; Kanazawa A; Poisson JF; Behr JB; Py S J Org Chem; 2017 Sep; 82(18):9866-9872. PubMed ID: 28752763 [TBL] [Abstract][Full Text] [Related]